Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Net Income towards Common Stockholders (2016 - 2025)

BioCorRx (BICX) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with -$471218.0 as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 61.62% to -$471218.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2025, up 48.14% year-over-year, with the annual reading at -$3.5 million for FY2025, 31.28% up from the prior year.
  • Net Income towards Common Stockholders hit -$471218.0 in Q4 2025 for BioCorRx, down from -$2830.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$2830.0 in Q3 2025 to a low of -$1.6 million in Q1 2021.
  • Historically, Net Income towards Common Stockholders has averaged -$1.1 million across 5 years, with a median of -$1.1 million in 2021.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 74.44% in 2024 and later skyrocketed 99.81% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$1.2 million in 2021, then increased by 3.96% to -$1.2 million in 2022, then rose by 16.15% to -$969009.0 in 2023, then dropped by 26.69% to -$1.2 million in 2024, then skyrocketed by 61.62% to -$471218.0 in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for BICX at -$471218.0 in Q4 2025, -$2830.0 in Q3 2025, and -$1.4 million in Q2 2025.